ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,317Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 86

$2.3M Total Retail Price of All Prescriptions

Rank: 5 out of 86

236 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

64% of this provider’s 236 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

12% of this provider’s 236 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

3% of this provider’s 7,012 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 49%.

Prescription Price

$141 was the average price of a prescription from this provider, compared to $288 among peers.

Prescriptions per Patient

69 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OXYCODONE HCL 787 263 S2 1 33
ENDOCET 611 328 S2 2 18
NEXIUM 438 184 3 14
OXYCONTIN 430 162 S2 4 48
ZOLPIDEM TARTRATE 417 165 5 11
PROAIR HFA 367 126 6 19
CRESTOR 310 170 7 9
OMEPRAZOLE 299 165 8 8
AMLODIPINE BESYLATE 284 188 9 3
METOPROLOL SUCCINATE 257 141 10 15
ADVAIR DISKUS 232 74 11 32
VOLTAREN 230 107 12 58
SIMVASTATIN 222 155 13 5
CLOTRIMAZOLE-BETAMETHASONE 205 102 14 42
LOVAZA 204 85 15 35
METOCLOPRAMIDE HCL 191 81 16 86
SPIRIVA 183 45 17 73
PREDNISONE 165 84 18 89
IBUPROFEN 163 38 19 65
AZELASTINE HCL 163 53 19 77
SINGULAIR 162 54 21 44
TAMSULOSIN HCL 160 116 22 45
POTASSIUM CHLORIDE 153 88 23 52
CELEBREX 153 85 23 61
FUROSEMIDE 152 85 25 21
ENALAPRIL MALEATE 148 63 26 24
DIOVAN HCT 145 107 27 20
ATORVASTATIN CALCIUM 145 78 27 12
LYRICA 130 44 29 69
FLUTICASONE PROPIONATE 130 36 29 51
CLOPIDOGREL 117 67 31 34
KETOCONAZOLE 113 32 32 102
AZITHROMYCIN 112 53 33 28
METFORMIN HCL 110 61 34 17
LEVOTHYROXINE SODIUM 109 74 35 16
EXFORGE 109 37 35 88
NASONEX 108 44 37 98
JANUMET 104 48 38 63
ALENDRONATE SODIUM 103 71 39 29
MELOXICAM 103 56 39 27
ESCITALOPRAM OXALATE 101 32 41 84
METOPROLOL TARTRATE 101 57 41 26
GABAPENTIN 96 27 43 25
FENTANYL 94 14 S2 44 132
NAPROXEN 92 52 45 82
ACTOS 92 59 45 49
CLONIDINE HCL 91 30 47 55
DIOVAN 84 46 48 40
RANITIDINE HCL 83 37 49 99
COMBIVENT 82 21 50 137
DOXAZOSIN MESYLATE 80 36 51 139
MONTELUKAST SODIUM 80 36 51 70
GLYBURIDE-METFORMIN HCL 79 39 R 53 59
MEGACE ES 79 43 R 53 140
POLYETHYLENE GLYCOL 3350 77 45 55 142
CARISOPRODOL 77 29 R 55 142
DULERA 77 20 55 142
SYMBICORT 76 31 58 146
HYDROXYZINE HCL 76 29 R 58 146
AMLODIPINE BESYLATE-BENAZEPRIL 75 40 60 64
LOSARTAN-HYDROCHLOROTHIAZIDE 73 50 61 41
LIDODERM 72 21 62 75
LACTULOSE 71 30 63 79
MECLIZINE HCL 70 29 64 112
LEVOFLOXACIN 69 25 65 54
PLAVIX 68 46 66 47
HYDROCHLOROTHIAZIDE 65 16 67 22
NORVIR 59 13 68 1
METFORMIN HCL ER 59 40 68 96
MOMETASONE FUROATE 58 14 70 164
CYMBALTA 58 11 70 87
TRUVADA 57 0 72 2
CYCLOBENZAPRINE HCL 57 28 R 72 85
JANUVIA 57 27 72 37
VENTOLIN HFA 57 0 72 167
TOBRAMYCIN-DEXAMETHASONE 57 43 72 167
HYDROMORPHONE HCL 56 25 S2 77 172
NOVOLOG MIX 70-30 FLEXPEN 55 36 78 100
HYDROCODONE-ACETAMINOPHEN 55 28 S3 78 103
LEVOCETIRIZINE DIHYDROCHLORIDE 54 28 80 106
ZETIA 53 15 81 78
VALACYCLOVIR 50 20 82 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.